ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 231 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $374,000 | +78.1% | 4,020 | +14.2% | 0.04% | +66.7% |
| Q3 2021 | $210,000 | -12.5% | 3,520 | 0.0% | 0.03% | -15.6% |
| Q2 2021 | $240,000 | -1.6% | 3,520 | 0.0% | 0.03% | -11.1% |
| Q1 2021 | $244,000 | -9.6% | 3,520 | 0.0% | 0.04% | -16.3% |
| Q4 2020 | $270,000 | +2.7% | 3,520 | 0.0% | 0.04% | -6.5% |
| Q3 2020 | $263,000 | +18.5% | 3,520 | 0.0% | 0.05% | +9.5% |
| Q2 2020 | $222,000 | +50.0% | 3,520 | 0.0% | 0.04% | +31.2% |
| Q1 2020 | $148,000 | -7.5% | 3,520 | 0.0% | 0.03% | +10.3% |
| Q4 2019 | $160,000 | -0.6% | 3,520 | 0.0% | 0.03% | -9.4% |
| Q3 2019 | $161,000 | -21.8% | 3,520 | 0.0% | 0.03% | -23.8% |
| Q2 2019 | $206,000 | +30.4% | 3,520 | 0.0% | 0.04% | +5.0% |
| Q1 2019 | $158,000 | +16.2% | 3,520 | +0.6% | 0.04% | +8.1% |
| Q4 2018 | $136,000 | -15.5% | 3,500 | 0.0% | 0.04% | -14.0% |
| Q3 2018 | $161,000 | +5.2% | 3,500 | 0.0% | 0.04% | -2.3% |
| Q2 2018 | $153,000 | +23.4% | 3,500 | 0.0% | 0.04% | +18.9% |
| Q1 2018 | $124,000 | -7.5% | 3,500 | 0.0% | 0.04% | -14.0% |
| Q4 2017 | $134,000 | +45.7% | 3,500 | 0.0% | 0.04% | +38.7% |
| Q3 2017 | $92,000 | +43.8% | 3,500 | 0.0% | 0.03% | +24.0% |
| Q2 2017 | $64,000 | – | 3,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 164,300 | $9,633,000 | 4.86% |
| Atika Capital Management LLC | 230,000 | $13,485,000 | 2.65% |
| DAFNA Capital Management LLC | 93,942 | $5,508,000 | 2.07% |
| PFM Health Sciences, LP | 1,828,378 | $107,198,000 | 2.04% |
| Perceptive Advisors | 1,380,171 | $80,919,000 | 1.86% |
| Eversept Partners, LP | 73,501 | $4,309,364 | 1.21% |
| Partner Investment Management, L.P. | 18,159 | $1,065,000 | 1.13% |
| Rhenman & Partners Asset Management AB | 170,000 | $9,967,000 | 1.10% |
| EMERALD ADVISERS, LLC | 425,510 | $24,948,000 | 1.00% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 388,418 | $22,773,000 | 0.90% |